Niuliva®

· Instituto Grifols, S.A.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Niuliva®, covering 2016-02-01 to 2016-02-01. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Niuliva® for the Prevention of Hepatitis B Virus Recurrence in Newly Orthotopic Liver Transplant Recipients [Phase 3]

See pricing